On Dec 07, major Wall Street analysts update their ratings for $Patterson (PDCO.US)$, with price targets ranging from $23 to $29.
BofA Securities analyst Allen Lutz maintains with a buy rating, and maintains the target price at $29.
Evercore analyst Elizabeth Anderson CFA maintains with a hold rating, and adjusts the target price from $22 to $23.
Baird analyst Jeff Johnson maintains with a hold rating, and adjusts the target price from $28 to $25.
Piper Sandler analyst Jason Bednar maintains with a hold rating, and adjusts the target price from $26 to $24.
Furthermore, according to the comprehensive report, the opinions of $Patterson (PDCO.US)$'s main analysts recently are as follows:
The firm noted that following another EPS miss and guidance reduction, it appears that the company's understanding of their own operations and market conditions, particularly in the dental segment, has not improved as management had earlier expected.
Patterson Companies' Q2 results were described as 'weak' due to challenges in lukewarm end markets along with specific company issues. Although expectations for lowered FY25 earnings predictions were previously present, achieving revised targets remains formidable, as approximately 70% of FY25 EPS is expected to come from the latter half, contrasting with the last three-year average of 59%.
Here are the latest investment ratings and price targets for $Patterson (PDCO.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间12月7日，多家华尔街大行更新了$帕特森 (PDCO.US)$的评级，目标价介于23美元至29美元。
美银证券分析师Allen Lutz维持买入评级，维持目标价29美元。
Evercore分析师Elizabeth Anderson CFA维持持有评级，并将目标价从22美元上调至23美元。
贝雅分析师Jeff Johnson维持持有评级，并将目标价从28美元下调至25美元。
派杰投资分析师Jason Bednar维持持有评级，并将目标价从26美元下调至24美元。
此外，综合报道，$帕特森 (PDCO.US)$近期主要分析师观点如下：
该公司注意到，在经历了另一次每股收益不达标和降低指引后，似乎公司对自身运营和市场状况的理解，特别是在牙科领域，并没有如管理层早期所预期的那样改善。
帕特森公司的第二季度业绩被形容为“疲软”，原因是温和的终端市场以及公司特定问题的挑战。尽管早前对降低2025财年的盈利预测已有预期，但实现修订后的目标仍然具有挑战性，因为预计约70%的2025财年每股收益将来自下半年的业绩，而这一比例与过去三年的平均水平相比为59%。
以下为今日4位分析师对$帕特森 (PDCO.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
